Inventor · disambiguated record
Niels Van De Donk
Also filed as: VAN DE DONK NIELS
4 granted patents·6 pending applications·31 citations·filing 2015–2024
72Inventor score
Files withJANSSEN BIOTECH INC10
Top patents by PatentIndex Score
10 records- 0192US11021543B2Immune modulation and treatment of solid tumors with antibodies that specifically bind CD38JANSSEN BIOTECH INC·Filed 2018·Granted Jun 1, 2021·13 cites·19 claims
- 0288US10604580B2Combination therapies with anti-CD38 antibodiesJANSSEN BIOTECH INC·Filed 2016·Granted Mar 31, 2020·18 cites·18 claims
- 0380US2025066501A1Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38JANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0475US2024301083A1Methods of treating cancers and enhancing efficacy of t cell redirecting therapeuticsJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0572US2024101697A1Methods of treating cancers and enhancing efficacy of t cell redirecting therapeuticsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0669US2021403592A1Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38JANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 0766US12065500B2Methods of treating cancers and enhancing efficacy of T cell redirecting therapeuticsJANSSEN BIOTECH INC·Filed 2019·Granted Aug 20, 2024·0 cites·28 claims
- 0866US12012461B2Methods of treating cancers and enhancing efficacy of T cell redirecting therapeuticsJANSSEN BIOTECH INC·Filed 2019·Granted Jun 18, 2024·0 cites·18 claims
- 0955US2017044265A1Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38JANSSEN BIOTECH INC·Filed 2016·Application pending·0 cites
- 1037US2016067205A1Combination Therapies with Anti-CD38 AntibodiesJANSSEN BIOTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Niels Van De Donk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →